SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Zebec's integrated products - real time payroll apps, on-chain payments infrastructure and networked DePIN - serve companies of all sizes, merchants and individuals and help transcend the boundaries of traditional banking and diminish the role of financial intermediaries.

Zebec Network

Zebec Network is trending as the community anticipates a major announcement, with speculation around partnerships and regulatory compliance driving excitement. Many compare ZBCN's potential to early XRP, urging others to accumulate and stake tokens. The community is closely watching for news that could catalyze a significant price movement, with some even suggesting a listing on a major exchange.

ProPetro Holding Corp. is an oilfield services company that engages in the provision of hydraulic fracturing and other complementary services. It operates through the following segments: Hydraulic Fracturing, Wireline, Cementing, and All Other. The Hydraulic Fracturing segment intends to optimize hydrocarbon flow paths during the completion phase of horizontal shale wellbores. The Wireline segment includes wireline and ancillary services on new oil well completions in the Permian Basin. The Cementing segment provides isolation between fluid zones behind the casing to minimize potential damage to hydrocarbon bearing formations or the integrity of freshwater aquifers and provides structural integrity for the casing by securing it to the earth. The company was founded by Dale Redman and Jeffrey David Smith in 2005 and is headquartered in Midland, TX.

ProPetro Holding Corp

ProPetro Holding is trending amid discussions about buybacks, potential contract wins, and insider trading activity. The community is weighing the company's future performance in the energy sector. Some are comparing it to peers and other energy stocks, while others are focusing on technical analysis and potential entry points.

Quantum Computing, Inc. engages in developing novel algorithms and solutions utilizing quantum and quantum-inspired computing to solve difficult problems in various industries. It leverages its expertise in finance, computing, security, mathematics, and physics to develop commercial applications for the financial, security, and government sectors. The company was founded on July 25, 2001 and is headquartered in Hoboken, NJ.

Quantum Computing Inc

QUBT is trending amid discussions about the future of quantum computing and comparisons to other companies in the sector like $IONQ and $QBTS. Community members are debating the company's valuation, potential government support, and its current commercial viability. Some are pointing to a recent private placement as a sign of institutional interest, while others express skepticism about the company's fundamentals.

MGM Resorts International is a holding company, which engages in the ownership and operations of casino resorts. The firm's casino resorts offer gaming, hotel, convention, dining, entertainment, retail, and other resort amenities. It operates through the following business segments: Las Vegas Strip Resorts, Regional Operations, MGM China, and MGM Digital. The Las Vegas Strip Resorts segment operates the following casino resorts: Bellagio, MGM Grand Las Vegas, Mandalay Bay, The Mirage, Luxor, New York-New, Excalibur, Park MGM, and Circus Las Vegas. The Regional Operations segment consists of the following casino resorts: MGM Grand Detroit in Detroit, Michigan, Beau Rivage in Biloxi, Mississippi, Gold Strike Tunica in Tunica, Mississippi, Borgata in Atlantic City, New Jersey, MGM National Harbor in Prince George’s County, Maryland, and MGM Springfield in Springfield, Massachusetts. The MGM China segment includes MGM Macau and MGM Cotai. The MGM Digital segment focuses on the online gaming portfolio, which consists primarily of Leo Vegas, which is headquartered in Sweden and Malta. The company was founded by Kerkor Kerkorian on January 29, 1986 and is headquartered in Las Vegas, NV.

MGM Resorts International

MGM is trending amid discussions about Macau's gaming revenue and its potential impact on casino stocks, with some analysts suggesting that fears of a shutdown due to a cyclone were overblown. The community is also focused on MGM's New York casino proposal receiving key support, which could affect the broader gaming landscape. Additionally, there's growing interest in the prediction market and its potential disruption to traditional casino revenues, influencing community perspectives on the industry's innovation.

Las Vegas Sands Corp. engages in the development of destination properties. It operates through the Macao and Singapore geographical segments. The Macao segment handles the operations of The Venetian Macao, The Londoner Macao, The Parisian Macao, The Plaza Macao and Four Seasons Macao, and Sands Macao. The Singapore segment includes the Marina Bay Sands. The company was founded by Sheldon Gary Adelson in August 2004 and is headquartered in Las Vegas, NV.

Las Vegas Sands Corp

Las Vegas Sands is trending as analysts debate the impact of Macau's recovery and construction disruptions on upcoming earnings. Mixed sentiment surrounds the stock as some see an attractive entry point, while others express concern over market share and future growth prospects. The community is closely monitoring revenue data and potential stimulus impacts from China.

YETI Holdings, Inc. engages in the design, marketing, and distribution of products for the outdoor and recreation market. Its products include coolers, drinkware, travel bags, backpacks, multipurpose buckets, outdoor chairs, blankets, dog bowls, apparel, and accessories. The company was founded by Roy J. Seiders and Ryan R. Seiders in 2006 and is headquartered in Austin, TX.

YETI Holdings Inc

YETI is trending amid discussions about unusual options activity, analyst ratings updates, and overall market sentiment. The community is debating the company's financial health, brand strength, and potential growth opportunities, with some highlighting concerns about tariffs and consumer spending habits. Takeover speculation and potential expansion into new markets, like military or firefighting equipment, are also circulating.

$WAGMI is a community-driven meme token built on the Solana blockchain, designed to bring positivity, unity, and humor into the crypto space. The project encourages community engagement through memes, social interaction, and token-based activities. It leverages Solana’s fast and low-cost infrastructure to allow for smooth on-chain interactions, such as token transfers, community games, and NFT integration. The goal is to foster a fun, inclusive ecosystem where holders feel they are part of a larger movement – "We Are Gonna Make It."

WAGMI

WAGMI is trending as community members express strong bullish sentiment and highlight its multi-platform presence within the crypto space. The community is focused on growth, unity, and diamond hands, while also noting potential CoinMarketCap listing rumors. $SOL and related meme coins $DOGE and $SHIB are also being mentioned by the community.

KeyCorp is a bank holding company, which engages in the provision of financial services. It operates through the Consumer Bank and Commercial Bank segments. The Consumer Bank segment offers deposit and investment products, personal finance and financial wellness services, lending, mortgage and home equity, student loan refinancing, credit card, treasury services, and business advisory services. The Commercial Bank segment focuses on serving the needs of middle market clients in seven industry sectors, consumer, energy, healthcare, industrial, public sector, real estate, and technology. The company was founded on December 31, 1958 and is headquartered in Cleveland, OH.

Keycorp

KeyCorp ($KEY) is trending due to a mix of analyst ratings updates and discussions around dividend yields, particularly in light of potential Fed rate cuts. Wells Fargo and Citigroup recently updated their ratings, contributing to the conversation. Community members are weighing the potential impact of these factors on KeyCorp's future performance, with some pointing to a potential rally.

Melco Resorts & Entertainment Ltd. engages in the management and development of casino gaming and entertainment resort facilities. The firm focuses on the administration of Mocha Clubs, Altira Macau, City of Dreams, Studio City, and City of Dreams Manila. It operates through the following geographical segments: Macau, the Philippines, Cyprus, and Corporate and Other. The company was founded by Yau Lung Ho in December 2004 and is headquartered in Hong Kong.

Melco Resorts & Entertainment Ltd - ADR

Melco Crown Entertainment Ltd.

Melco Resorts is trending as investors assess the impact of Macau's recovery and easing travel restrictions, with the community actively discussing Golden Week data and potential catalysts like the reopening of properties and expansion into Sri Lanka. Community members are weighing positive GGR updates against concerns around the company's debt and exposure to geopolitical risks. Bullish sentiment is building around Macau's potential to return to pre-pandemic levels, with some eyeing catalysts related to visitation and GGR.

Wynn Resorts Ltd. is a holding company, which engages in the design, development, and operation of destination casino resorts. It operates through the following segments: Wynn Palace, Wynn Macau, Las Vegas Operations, Encore Boston Harbor, and Corporate and Other. The company was founded by Stephen Alan Wynn, Elaine P. Wynn, and Kazuo Okada in 2002 and is headquartered in Las Vegas, NV.

Wynn Resorts Ltd.

Wynn Resorts is trending as the community discusses the potential impact of Macau's gaming revenue and expansion into the UAE. Recent news highlights analyst ratings and discussions around financial performance, with some concern around a potential fall in share price. Community members also discuss both bullish and bearish option flows, and a settlement with investors.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Shares of iBio, Inc.(IBIO) were in the spotlight on Monday after the company <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/news-release/2025/04/07/3056559/0/en/iBio-Announces-IBIO-600-Non-Human-Primate-Data-Showing-Extended-Half-Life-and-Muscle-Growth-and-Interim-In-Vivo-Results-for-First-in-Class-Activin-E-Antibody-Advancing-Cardiometabo.html">announced</a> positive data from a study conducted in animals for its lead asset IBIO-600.The company said data from a study on elderly and obese non-human primates shows that the anti-myostatin antibody could provide a weight loss treatment option while preserving and promoting muscle growth.The study consisted of a single administration of two dose levels: 5mg/kg and a high dose of 50mg/kg.Shares of the company were down by over 43% on Monday noon amid a broader market decline.Notably, the study does not prove statistical significance and only involves a single administration of the antibody.However, the study demonstrated an extended half-life for the antibody, potentially enabling a once three to six-month dosing schedule in humans, the company said.CEO Martin Brenner said the company is on track for a regulatory submission for the antibody in the first quarter (Q1) of 2026.iBio in-licensed IBIO-600 from AstralBio, Inc. in January. The company paid AstralBio $750,000 by issuing its common stock as an upfront payment and said AstralBio will also be eligible for development and commercialization milestone payments totaling up to $28 million.On Monday, the company also announced preclinical data for an Activin E antibody and said that the antibody showed positive results in an exploratory study with obese mice, highlighting its potential as a treatment for obesity.On Stocktwits, retail sentiment about iBio remained in the ‘bearish’ territory while message volume rose marginally within ‘low’ levels over the past 24 hours.<figure class="image"><img style="aspect-ratio:654/152;" src="https://news.stocktwits-cdn.com/Screenshot_2025_04_07_at_11_29_58_AM_png_24aaec3e9f.webp" alt="IBIO's Sentiment Meter and Message Volume as of 11:30 a.m. ET on April 7, 2025 | Source: Stocktwits" width="654" height="152"><figcaption>IBIO's Sentiment Meter and Message Volume as of 11:30 a.m. ET on April 7, 2025 | Source: Stocktwits</figcaption></figure> A Stocktwits user expressed surprise at the stock’s downward trajectory.<stembedurl>https://stocktwits.com/Skypier2/message/610731384</stembedurl>Another opined that the company needs to protect itself against any potential hostile takeovers.<stembedurl>https://stocktwits.com/dcpanda/message/610733604</stembedurl><a href="https://stocktwits.com/symbol/IBIO">iBio shares</a> are down by over 24% this year and by over 19% over the past 12 months.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/federal-reserve-board-of-governors-will-meet-today/chf1DjqRb7o">Federal Reserve Board Of Governors Will Meet Today — Traders Factor In 4 Rate Cuts This Year</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Stock market down on a black background. | Image source: Yuichiro Chino via Getty Images

iBio Stock Plummets Despite Positive Data On Weight-Loss Treatment Antibody: Retail Stays Bearish

However, the company said that the study does not prove statistical significance and only involves a single administration of the antibody. 

Equity

Biotechs have underperformed the broader market this year, and these stock are at crossroads as they await the new administration under Donald Trump to take over shortly after the new year.The SPDR S&amp;P Biotech ETF ($XBI) has gained 9.2% for the year-to-date period compared to the 25%+ gain for the S&amp;P 500 Index. The iShares Biotechnology ETF ($IBB), which has a relatively higher proportion of mid- and large-cap stocks, has also added under 10% so far this year.The underperformance takes away the sheen of the industry’s defensive credentials.&nbsp;R&amp;D momentum slowed during the year, as is evident from the new molecular entity approvals, which number 38 so far this year compared to 47 for the same period last year.&nbsp;&nbsp;Most biotech companies operate deep in the red for a very long time until they could begin commercializing products. They rely on debt financing which came to be expensive in an elevated interest rate environment.&nbsp;With a change of guard on the political arena following Trump's win, the outlook for the industry is yet unclear.Morgan Stanley Head of Policy Monica Guerra&nbsp;<a target="_blank" rel="noopener noreferrer nofollow" href="https://www.morganstanley.com/articles/trump-re-election-implications-for-markets">said&nbsp;</a>in a recent note that deregulation is likely to be a major theme expected during the second term. “Less stringent requirements in pharmaceuticals and biotechnology, meanwhile, could help those industries by prompting accelerated drug approvals,” she said.BMO Capital Markets analyst Evan Seigerman said the election results are “modestly positive” for the biopharma sector,&nbsp;<a target="_blank" rel="noopener noreferrer nofollow" href="https://www.fiercepharma.com/pharma/trump-white-house-again-whats-ahead-pharma">according</a> to FiercePharma. The analyst sees potential deprioritization of the Internal Revenue Service, likely less Federal Trade Commission interference, and lower corporate taxes.Jefferies analysts does not expect the proposed drug pricing reforms to pass as the Republican legislators are divided over the proposals.Amid the ongoing discussions about the implications of Trump’s presidency, here’s a few biopharma stocks that are on retail’s radar (based on the number of followers on the Stocktwits platform):Moderna, Inc. ($ MRNA): 107,109 watchersNovavax, Inc. ($NVAX): 101,846Pfizer, Inc. ($PFE): 99,425 watchersiBio, Inc. ($IBIO): 93,617 watchersInovia Pharma, Inc. ($INO): 93,414 watchersJaguar Health ($JAGX): 81,859 watchersGilead Sciences, Inc. ($GILD): 77,094 watchersVaxart, Inc. ($VXRT): 75,807 watchersTonix Pharmaceutical Holding Corp. ($TNXP): 72,666 watchersSorrento Therapeutics, Inc. ($SRNE): 68,474 watchersRead Next:&nbsp; <a href="https://stocktwits.com/news-articles/markets/equity/block-ceo-jack-dorsey-weighs-in-on-election-impact/cJ4EMJ3Raj">Block CEO Jack Dorsey Keeps Fingers Crossed Over Regulatory Environment As Trump Makes A Comeback</a>For updates and corrections email newsroom@stocktwits.com&nbsp;

GOP lawmakers are divided over drug pricing reforms.

Will Trump 2.0 Nurse Biotechs Back To Health: 10 Stocks Retail Is Watching

Less stringent requirements in pharmaceuticals and biotechnology could help by prompting accelerated drug approvals.

iBio, Inc. is an AI-driven innovator that develops next-generation biopharmaceuticals using computational biology and 3D-modeling of subdominant and conformational epitopes, prospectively enabling the discovery of new antibody treatments for hard to target cancers, and other diseases. It focuses on decreasing drug failures, shortening drug development timelines and opening up new frontiers against the most promising targets. The company was founded on April 17, 2008 and is headquartered in San Diego, CA.

iBio Inc

Will PepsiCo ($PEP) beat quarterly earnings? 
 
*Powered by Polymarket

Stocktwits

PepsiCo Inc

) beat quarterly earnings? 
 
*Powered by Polymarket

IBIO
iBio Inc

Feed

News

Sentiment

Fundamentals

Info

Latest IBIO News

IBIO iBio Inc